William C Cushman Selected Research

Thiazides

1/2022	Design of a pragmatic clinical trial embedded in the Electronic Health Record: The VA's Diuretic Comparison Project.
1/2017	Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical Trial.
3/2016	Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial.
5/2015	Real-world evidence supports optimally dosed thiazide-type diuretics as preferred in treatment regimens of older adults with hypertension.
11/2014	Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT.
8/2012	Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension.
8/2012	Module 2: Rethinking the role of thiazide-type diuretics in the management of hypertension: which diuretic is best?
6/2010	Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death.
5/2010	Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic use.
4/2009	Antihypertensive prescriptions for newly treated patients before and after the main antihypertensive and lipid-lowering treatment to prevent heart attack trial results and seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure guidelines.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William C Cushman Research Topics

Disease

47	Hypertension (High Blood Pressure) 05/2024 - 01/2002
43	Myocardial Infarction 05/2024 - 11/2002
41	Type 2 Diabetes Mellitus (MODY) 10/2022 - 01/2002
31	Stroke (Strokes) 05/2024 - 11/2003
30	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 11/2002
26	Heart Failure 12/2022 - 11/2002
11	Acute Coronary Syndrome 10/2018 - 10/2011
7	Isolated Systolic Hypertension 10/2019 - 03/2002
7	Coronary Disease (Coronary Heart Disease) 01/2017 - 11/2002
6	Hypotension (Low Blood Pressure) 10/2023 - 11/2015
6	Unstable Angina 12/2022 - 10/2013
6	Chronic Renal Insufficiency 01/2021 - 05/2003
6	Diabetes Mellitus 01/2020 - 04/2009
5	Syncope (Fainting) 11/2022 - 11/2015
5	Acute Kidney Injury (Acute Renal Failure) 11/2022 - 11/2015
4	Orthostatic Hypotension (Postural Hypotension) 10/2023 - 10/2016
4	Neoplasms (Cancer) 01/2023 - 10/2013
4	Kidney Diseases (Kidney Disease) 01/2022 - 03/2016
3	Hypokalemia 05/2024 - 05/2012
3	Bradycardia 11/2022 - 01/2020
3	Prediabetic State (Prediabetes) 01/2021 - 08/2017
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 05/2009
3	Essential Hypertension 01/2018 - 12/2012
3	Obesity 02/2017 - 05/2003
2	Atrial Fibrillation 01/2022 - 10/2017
2	Overweight 02/2017 - 01/2017
2	Peripheral Arterial Disease 11/2014 - 09/2006
2	Hypoglycemia (Reactive Hypoglycemia) 10/2013 - 03/2011
2	Albuminuria 05/2012 - 08/2010
2	Dyslipidemias (Dyslipidemia) 07/2010 - 06/2007
2	Sleep Apnea Syndromes (Sleep Apnea) 06/2008 - 06/2008
1	Atrial Flutter (Flutter, Atrial) 01/2022
1	Erectile Dysfunction 01/2021
1	Vascular Diseases (Vascular Disease) 01/2021
1	Ischemic Stroke 01/2020
1	Cognitive Dysfunction 01/2020
1	Body Weight (Weight, Body) 01/2018
1	Headache (Headaches) 09/2017
1	Nasopharyngitis 09/2017
1	Dizziness (Lightheadedness) 09/2017
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2016

Drug/Important Bio-Agent (IBA)

51	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 03/2002
31	LipidsIBA 10/2017 - 11/2002
30	Chlorthalidone (Chlortalidone)FDA LinkGeneric 05/2024 - 11/2002
26	DiureticsIBA 05/2024 - 11/2002
20	Amlodipine (Norvasc)FDA LinkGeneric 01/2018 - 01/2002
19	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 05/2024 - 10/2005
19	Lisinopril (Prinivil)FDA LinkGeneric 01/2018 - 11/2002
15	ThiazidesIBA 01/2022 - 05/2003
13	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017 - 11/2002
12	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2005
11	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2017 - 11/2002
10	dulaglutideIBA 10/2022 - 01/2018
9	alogliptinIBA 08/2018 - 10/2011
6	omega-Chloroacetophenone (Mace)IBA 11/2022 - 05/2015
5	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 12/2022 - 12/2003
5	ElectrolytesIBA 11/2022 - 11/2015
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 10/2011
5	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 01/2018
5	azilsartan medoxomilIBA 11/2018 - 08/2012
5	Doxazosin (Cardura)FDA LinkGeneric 02/2013 - 11/2002
4	CreatinineIBA 01/2022 - 08/2010
4	IncretinsIBA 11/2020 - 01/2018
4	Angiotensin Receptor AntagonistsIBA 11/2018 - 05/2003
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2017 - 06/2008
4	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2016 - 10/2011
4	Irbesartan FDA LinkGeneric 01/2008 - 10/2005
3	hydroxide ionIBA 01/2021 - 10/2016
3	Glucagon-Like Peptide-1 ReceptorIBA 11/2020 - 01/2019
3	Blood Glucose (Blood Sugar)IBA 01/2020 - 08/2010
3	Insulin (Novolin)FDA Link 01/2020 - 05/2017
3	olmesartanIBA 11/2018 - 08/2012
3	Valsartan (Vals)FDA Link 04/2012 - 08/2011
2	PotassiumIBA 05/2024 - 05/2012
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021 - 01/2021
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2018 - 10/2013
2	Retinaldehyde (Retinal)IBA 01/2018 - 08/2010
2	CholesterolIBA 02/2017 - 01/2017
2	SodiumIBA 11/2016 - 08/2012
2	Fenofibrate (CiL)FDA LinkGeneric 07/2010 - 04/2010
2	Simvastatin (Zocor)FDA LinkGeneric 07/2010 - 04/2010
2	Fibric Acids (Fibrates)IBA 04/2010 - 06/2007
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2010 - 06/2007
2	Drug CombinationsIBA 06/2008 - 06/2008
2	Losartan (Cozaar)FDA LinkGeneric 11/2003 - 03/2002
1	AlbuminsIBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	3,5-diisopropylsalicylic acid (DIPS)IBA 01/2019
1	welan (S 130)IBA 10/2018
1	Olmesartan Medoxomil (Votum)FDA Link 09/2017
1	Troponin IIBA 05/2017
1	dipeptidaseIBA 05/2016

Therapy/Procedure

41	Therapeutics 10/2023 - 11/2002
7	Glycemic Control 01/2021 - 06/2007
3	Subcutaneous Injections 01/2019 - 01/2018
2	Vitrectomy 08/2010 - 07/2010
2	Light Coagulation 08/2010 - 07/2010
1	Drug Therapy (Chemotherapy) 11/2023
1	Injections 01/2018